跳转至内容
Merck
CN

20832-U

ORBO 402 Tenax® TA 经过特殊处理(35/60),100/50mg

W,W,W separators, O.D. × L 8 mm × 100 mm, pkg of 50 ea

别名:

ORBO Tenax® TA

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NB.24
UNSPSC Code:
12190000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


material

W,W,W separators

Quality Level

agency

NIOSH 2507,2545,7905, OSHA 43

product line

ORBO

composition

Bed A, 100 mg , Bed B, 50 mg

packaging

pkg of 50 ea

manufacturer/tradename

ORBO 402

technique(s)

active air sampling: suitable

O.D. × L

8 mm × 100 mm

matrix

Tenax TA (specially treated)

particle size

35-60 mesh

application(s)

air monitoring
environmental
industrial hygiene

General description

ORBO 402 Tenax® TA吸附管(特别处理,35/60,100/50 mg)用于气体或蒸汽采样。它是装填双层填充床的玻璃管,双层填充床采用相同的选择性吸附剂,中间由玻璃棉或泡沫隔开。双层设计使较少一层填充床可作为后备,捕获因过载而穿透前一层填充床的样品。

适用气相色谱-质谱(GC-MS)仪器,常用于呼吸分析。

Application

ORBO 402 Tenax® TA吸附管(特别处理,35/60,100/50 mg)可作为吸附剂采集空气样品,用于GC/MS法测定环境中的微量苯。

Legal Information

ORBO is a trademark of Sigma-Aldrich Co. LLC
Tenax is a registered trademark of Buchem B.V.


pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Determination of benzene at trace levels in air by a novel method based on solid-phase microextraction gas chromatography/mass spectrometry.
Alessandro S, et al.
Rapid Communications in Mass Spectrometry, 15, 2404-2408 (2001)
Low-cost desorption unit coupled with a gold nanoparticles gas sensors array for the analysis of volatile organic compounds emitted from the exhaled breath (gastric cancer and control samples.
Cristhian Manuel D, et al.
Microelectronic Engineering, 237, 111483-111483 (2021)
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine



全球贸易项目编号

货号GTIN
20832-U04061838769664